Orkambi
Market Access/ News/ News/ Top stories
Orkambi parents start ‘buyers club’ to import generic version of CF drug
Vertex’s CF drug gets label extension as pricing row continues
George Underwood
cystic fibrosis, NICE, Orkambi, Vertex
0 Comment
UK urges Vertex to accept ‘generous’ Orkambi funding offer
Piotr Wnuk
cystic fibrosis, Cystic Fibrosis Trust, Kalydeco, NHS England, Orkambi, Symdeko, Vertex
0 Comment
10 drugs – and their prices – which changed pharma in 2015
Andrew McConaghie
Entresto, FDA approvals, ICER, Opdivo, Orkambi
0 Comment
In a record-breaking year for pharma, which drugs were the most outstanding?
Biogen signs $1bn gene therapy deal; CF trial shows promise
Andrew McConaghie
Biogen, cystic fibrosis, gene therapy, Orkambi, Vertex
0 Comment
Biogen following move into regenerative medicine